Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Polymorphic repeat in AIB1 does not alter breast cancer risk.

Breast cancer research : BCR - 1 Jan 2000

Haiman C A, Hankinson S E, Spiegelman D, Colditz G A, Willett W C, Speizer F E, Brown M, Hunter D J

Abstract excerpt

STATEMENT OF FINDINGS: We assessed the association between a glutamine repeat polymorphism in AIB1 and breast cancer risk in a case-control study (464 cases, 624 controls) nested within the Nurses' Health Study cohort. We observed no association between AIB1 genotype and breast cancer incidence, or specific tumor characteristics. These findings suggest that AIB1 repeat genotype does not influence postmenopausal...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to DNA, Neoplasm
Share to DNA Primers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glutamine

Share to Linkage Disequilibrium

Share to Microsatellite Repeats

Share to Sequence Analysis, DNA

Share to Transcription Factors

Source

Open in PubMed Open full text

Identifiers

PMID: 11056690
DOI: 10.1186/bcr82
PMCID: PMC13920

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Polymorphic repeat in AIB1 does not alter breast cancer risk.PMID 11056690Read ↗

The AIB1 polyglutamine repeat does not modify breast cancer risk in BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

The AIB1 glutamine repeat polymorphism is not associated with risk of breast cancer before age 40 years in Australian women.Semantic proximity Read ↗

AIB1 polymorphisms with breast cancer susceptibility: a pooled analysis of variation in BRCA1/2 mutation carriers and non-carriers.Semantic proximity Read ↗

Breast cancer risk in BRCA1 and BRCA2 mutation carriers and polyglutamine repeat length in the AIB1 gene.Semantic proximity Read ↗

Polymorphic exonic CAG microsatellites in the gene amplified in breast cancer (AIB1 gene).Semantic proximity Read ↗

Polyglutamine repeat length in the AIB1 gene modifies breast cancer susceptibility in BRCA1 carriers.Semantic proximity Read ↗

Polyglutamine repeat length in the NCOA3 does not affect risk in familial breast cancer.Semantic proximity Read ↗

The HRAS1 variable number of tandem repeats and risk of breast cancer.Semantic proximity Read ↗

A sequence repeat in the insulin-like growth factor-1 gene and risk of breast cancer.Semantic proximity Read ↗

The AIB1 gene polyglutamine repeat length polymorphism contributes to risk of epithelial ovarian cancer risk: a case-control study.Semantic proximity Read ↗

AIB1 polymorphisms predict aggressive ovarian cancer phenotype.Semantic proximity Read ↗

Polymorphic repeat length in the AIB1 gene and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a meta-analysis of observational studies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.